CD44 and prostate carcinoma: The CTCs identified with GLV-1h254 in mice bearing human PC-3 prostate cancer xenografts displayed high levels of the expression of the CSC markers CD44 and aldehyde dehydrogenase 1 (ALDH1) as well as the EMT markers vimentin and N-cadherin (Figure 2A).